Cargando…
National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011
Background. Several guidelines for Parkinson's disease (PD) management were recently updated. We examined temporal trends for antiparkinsonism drugs in Taiwan. Methods. Antiparkinsonism prescriptions, including levodopa, ergot/nonergot dopamine agonists (DAs), amantadine, selegiline, entacapone...
Autores principales: | Liu, Weng-Ming, Wu, Ruey-Meei, Chang, Chia-Hsuin, Lin, Jou-Wei, Liu, Ying-Chun, Lin, Chin-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775810/ https://www.ncbi.nlm.nih.gov/pubmed/26989558 http://dx.doi.org/10.1155/2016/1859321 |
Ejemplares similares
-
Antiparkinson Prodrugs
por: Di Stefano, Antonio, et al.
Publicado: (2008) -
Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015) -
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
por: Lee, Yen-Chieh, et al.
Publicado: (2014) -
The impact of nonmotor symptoms on quality of life in patients with Parkinson’s disease in Taiwan
por: Liu, Weng-Ming, et al.
Publicado: (2015) -
An Analysis of the Activating System Including Its use for Screening Antiparkinson Drugs
por: Himwich, Harold E., et al.
Publicado: (1955)